Cargando…
Optimal Reopening Pathways With COVID-19 Vaccine Rollout and Emerging Variants of Concern
We developed a stochastic optimization technology based on a COVID-19 transmission dynamics model to determine optimal pathways from lockdown toward reopening with different scales and speeds of mass vaccine rollout in order to maximize social economical activities while not overwhelming the health...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452896/ https://www.ncbi.nlm.nih.gov/pubmed/34557471 http://dx.doi.org/10.3389/fpubh.2021.729141 |
_version_ | 1784570170311704576 |
---|---|
author | Xiao, Yanyu Chen, Shengyuan Zhu, Yi McCarthy, Zachary Bragazzi, Nicola Luigi Asgary, Ali Wu, Jianhong |
author_facet | Xiao, Yanyu Chen, Shengyuan Zhu, Yi McCarthy, Zachary Bragazzi, Nicola Luigi Asgary, Ali Wu, Jianhong |
author_sort | Xiao, Yanyu |
collection | PubMed |
description | We developed a stochastic optimization technology based on a COVID-19 transmission dynamics model to determine optimal pathways from lockdown toward reopening with different scales and speeds of mass vaccine rollout in order to maximize social economical activities while not overwhelming the health system capacity in general, hospitalization beds, and intensive care units in particular. We used the Province of Ontario, Canada as a case study to demonstrate the methodology and the optimal decision trees; but our method and algorithm are generic and can be adapted to other settings. Our model framework and optimization strategies take into account the likely range of social contacts during different phases of a gradual reopening process and consider the uncertainties of these contact rates due to variations of individual behaviors and compliance. The results show that, without a mass vaccination rollout, there would be multiple optimal pathways should this strategy be adopted right after the Province's lockdown and stay-at-home order; however, once reopening has started earlier than the timing determined in the optimal pathway, an optimal pathway with similar constraints no longer exists, and sub-optimal pathways with increased demand for intensive care units can be found, but the choice is limited and the pathway is narrow. We also simulated the situation when the reopening starts after the mass vaccination has been rolled out, and we concluded that optimal pathways toward near pre-pandemic activity level is feasible given an accelerated vaccination rollout plan, with the final activity level being determined by the vaccine coverage and the transmissibility of the dominating strain. |
format | Online Article Text |
id | pubmed-8452896 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84528962021-09-22 Optimal Reopening Pathways With COVID-19 Vaccine Rollout and Emerging Variants of Concern Xiao, Yanyu Chen, Shengyuan Zhu, Yi McCarthy, Zachary Bragazzi, Nicola Luigi Asgary, Ali Wu, Jianhong Front Public Health Public Health We developed a stochastic optimization technology based on a COVID-19 transmission dynamics model to determine optimal pathways from lockdown toward reopening with different scales and speeds of mass vaccine rollout in order to maximize social economical activities while not overwhelming the health system capacity in general, hospitalization beds, and intensive care units in particular. We used the Province of Ontario, Canada as a case study to demonstrate the methodology and the optimal decision trees; but our method and algorithm are generic and can be adapted to other settings. Our model framework and optimization strategies take into account the likely range of social contacts during different phases of a gradual reopening process and consider the uncertainties of these contact rates due to variations of individual behaviors and compliance. The results show that, without a mass vaccination rollout, there would be multiple optimal pathways should this strategy be adopted right after the Province's lockdown and stay-at-home order; however, once reopening has started earlier than the timing determined in the optimal pathway, an optimal pathway with similar constraints no longer exists, and sub-optimal pathways with increased demand for intensive care units can be found, but the choice is limited and the pathway is narrow. We also simulated the situation when the reopening starts after the mass vaccination has been rolled out, and we concluded that optimal pathways toward near pre-pandemic activity level is feasible given an accelerated vaccination rollout plan, with the final activity level being determined by the vaccine coverage and the transmissibility of the dominating strain. Frontiers Media S.A. 2021-09-07 /pmc/articles/PMC8452896/ /pubmed/34557471 http://dx.doi.org/10.3389/fpubh.2021.729141 Text en Copyright © 2021 Xiao, Chen, Zhu, McCarthy, Bragazzi, Asgary and Wu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Xiao, Yanyu Chen, Shengyuan Zhu, Yi McCarthy, Zachary Bragazzi, Nicola Luigi Asgary, Ali Wu, Jianhong Optimal Reopening Pathways With COVID-19 Vaccine Rollout and Emerging Variants of Concern |
title | Optimal Reopening Pathways With COVID-19 Vaccine Rollout and Emerging Variants of Concern |
title_full | Optimal Reopening Pathways With COVID-19 Vaccine Rollout and Emerging Variants of Concern |
title_fullStr | Optimal Reopening Pathways With COVID-19 Vaccine Rollout and Emerging Variants of Concern |
title_full_unstemmed | Optimal Reopening Pathways With COVID-19 Vaccine Rollout and Emerging Variants of Concern |
title_short | Optimal Reopening Pathways With COVID-19 Vaccine Rollout and Emerging Variants of Concern |
title_sort | optimal reopening pathways with covid-19 vaccine rollout and emerging variants of concern |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452896/ https://www.ncbi.nlm.nih.gov/pubmed/34557471 http://dx.doi.org/10.3389/fpubh.2021.729141 |
work_keys_str_mv | AT xiaoyanyu optimalreopeningpathwayswithcovid19vaccinerolloutandemergingvariantsofconcern AT chenshengyuan optimalreopeningpathwayswithcovid19vaccinerolloutandemergingvariantsofconcern AT zhuyi optimalreopeningpathwayswithcovid19vaccinerolloutandemergingvariantsofconcern AT mccarthyzachary optimalreopeningpathwayswithcovid19vaccinerolloutandemergingvariantsofconcern AT bragazzinicolaluigi optimalreopeningpathwayswithcovid19vaccinerolloutandemergingvariantsofconcern AT asgaryali optimalreopeningpathwayswithcovid19vaccinerolloutandemergingvariantsofconcern AT wujianhong optimalreopeningpathwayswithcovid19vaccinerolloutandemergingvariantsofconcern |